Skip to main content
Top
Published in: BMC Urology 1/2018

Open Access 01-12-2018 | Research article

Effect of sample time on urinary lithogenic risk indexes in healthy and stone-forming adults and children

Authors: Adrian Rodriguez, Concepcion Saez-Torres, Concepcion Mir, Paula Casasayas, Nuria Rodriguez, Dolores Rodrigo, Guiem Frontera, Juan Manuel Buades, Cristina Gomez, Antonia Costa-Bauza, Felix Grases

Published in: BMC Urology | Issue 1/2018

Login to get access

Abstract

Background

The diagnosis and follow-up of stone forming patients is usually performed by analysis of 24-h urine samples. However, crystallization risk varies throughout the day, being higher at night. The main objective of this study is to evaluate the urinary crystallization risk in adults and children by calculating risk indexes based on different collection periods.

Methods

The study included 149 adults (82 healthy and 67 stone-formers) and 108 children (87 healthy and 21 stone-formers). 24-h urine was collected, divided into 12-h daytime sample (8 am to 8 pm), and 12-h overnight sample (8 pm to 8 am next morning). Solute concentrations, the calcium to citrate ratio (Ca/Cit), and the ion activity product of calcium oxalate (AP[CaOx]) and calcium phosphate (AP[CaP]) were calculated in each 12-h sample and in overall 24-h urine. Assessments were also related to stone type.

Results

Ca/Cit and AP(CaOx) were significantly higher in stone forming patients than in healthy subjects. The 12-h overnight samples had the highest values for both risk indexes, confirming a greater risk for crystallization at night. The AP(CaP) index was significantly higher in patients with pure hydroxyapatite stones than healthy controls, but was not significantly different between stone-formers overall and healthy controls.

Conclusions

The calculation of risk indexes is a simple method that clinicians can use to estimate crystallization risk. For this purpose, the use of 12-h overnight urine may be a reliable alternative to 24-h collections.
Literature
1.
go back to reference Scales CD Jr, Smith AC, Hanley JM, Saigal CS. Prevalence of kidney stones in the United States. Eur Urol. 2012;62:160–5.CrossRef Scales CD Jr, Smith AC, Hanley JM, Saigal CS. Prevalence of kidney stones in the United States. Eur Urol. 2012;62:160–5.CrossRef
2.
go back to reference VanDervoort K, Wiesen J, Frank R, Vento S, Crosby V, Chandra M, et al. Urolithiasis in pediatric patients: a single center study of incidence, clinical presentation and outcome. J Urol. 2007;177:2300–5.CrossRef VanDervoort K, Wiesen J, Frank R, Vento S, Crosby V, Chandra M, et al. Urolithiasis in pediatric patients: a single center study of incidence, clinical presentation and outcome. J Urol. 2007;177:2300–5.CrossRef
3.
go back to reference Cloutier J, Villa L, Traxer O, Daudon M. Kidney stone analysis: “give me your stone, I will tell you who you are!”. World J Urol. 2015;33:157–69.CrossRef Cloutier J, Villa L, Traxer O, Daudon M. Kidney stone analysis: “give me your stone, I will tell you who you are!”. World J Urol. 2015;33:157–69.CrossRef
4.
go back to reference Costa-Bauza A, Ramis M, Montesinos V, Grases F, Conte A, Piza P, et al. Type of renal calculi: variation with age and sex. World J Urol. 2007;25:415–21.CrossRef Costa-Bauza A, Ramis M, Montesinos V, Grases F, Conte A, Piza P, et al. Type of renal calculi: variation with age and sex. World J Urol. 2007;25:415–21.CrossRef
5.
go back to reference Grases F, Costa-Bauza A, Ramis M, Montesinos V, Conte A. Simple classification of renal calculi closely related to their micromorphology and etiology. Clin Chim Acta. 2002;322:29–36.CrossRef Grases F, Costa-Bauza A, Ramis M, Montesinos V, Conte A. Simple classification of renal calculi closely related to their micromorphology and etiology. Clin Chim Acta. 2002;322:29–36.CrossRef
6.
go back to reference Grases F, Costa-Bauza A, Bonarriba CR, Pieras EC, Fernandez RA, Rodriguez A. On the origin of calcium oxalate monohydrate papillary renal stones. Urolithiasis. 2015;43(Suppl 1):33–9.CrossRef Grases F, Costa-Bauza A, Bonarriba CR, Pieras EC, Fernandez RA, Rodriguez A. On the origin of calcium oxalate monohydrate papillary renal stones. Urolithiasis. 2015;43(Suppl 1):33–9.CrossRef
7.
go back to reference Sikora P, Zajaczkowska M, Hoppe B. Assessment of crystallization risk formulas in pediatric calcium stone-formers. Pediatr Nephrol. 2009;24:1997–2003.CrossRef Sikora P, Zajaczkowska M, Hoppe B. Assessment of crystallization risk formulas in pediatric calcium stone-formers. Pediatr Nephrol. 2009;24:1997–2003.CrossRef
8.
go back to reference Baumann JM, Affolter B. From crystalluria to kidney stones, some physicochemical aspects of calcium nephrolithiasis. World J Nephrol. 2014;3:256–67.CrossRef Baumann JM, Affolter B. From crystalluria to kidney stones, some physicochemical aspects of calcium nephrolithiasis. World J Nephrol. 2014;3:256–67.CrossRef
9.
go back to reference Arrabal-Polo MA, Arrabal-Martin M, Arias-Santiago S, Garrido-Gomez J, Poyatos-Andujar A, Zuluaga-Gomez A. Importance of citrate and the calcium : citrate ratio in patients with calcium renal lithiasis and severe lithogenesis. BJU Int. 2013;111:622–7.CrossRef Arrabal-Polo MA, Arrabal-Martin M, Arias-Santiago S, Garrido-Gomez J, Poyatos-Andujar A, Zuluaga-Gomez A. Importance of citrate and the calcium : citrate ratio in patients with calcium renal lithiasis and severe lithogenesis. BJU Int. 2013;111:622–7.CrossRef
10.
go back to reference Tiselius HG. Risk formulas in calcium oxalate urolithiasis. World J Urol. 1997;15:176–85.CrossRef Tiselius HG. Risk formulas in calcium oxalate urolithiasis. World J Urol. 1997;15:176–85.CrossRef
11.
go back to reference Tiselius HG. Estimated levels of supersaturation with calcium phosphate and calcium oxalate in the distal tubule. Urol Res. 1997;25:153–9.CrossRef Tiselius HG. Estimated levels of supersaturation with calcium phosphate and calcium oxalate in the distal tubule. Urol Res. 1997;25:153–9.CrossRef
12.
go back to reference Grases F, Costa-Bauza A, Prieto RM, Arrabal M, De Haro T, Lancina JA, et al. Urinary lithogenesis risk tessts: comparison of a commercial kit and a laboratory prototype test. Scand J Urol Nephrol. 2011;45:312–8.CrossRef Grases F, Costa-Bauza A, Prieto RM, Arrabal M, De Haro T, Lancina JA, et al. Urinary lithogenesis risk tessts: comparison of a commercial kit and a laboratory prototype test. Scand J Urol Nephrol. 2011;45:312–8.CrossRef
13.
go back to reference Saez-Torres C, Grases F, Rodrigo D, Garcia-Raja AM, Gomez C, Frontera G. Risk factors for urinary stones in healthy schoolchildren with and without a family hystory of nephrolithiasis. Pedriatr Nephrol. 2013;28:639–45.CrossRef Saez-Torres C, Grases F, Rodrigo D, Garcia-Raja AM, Gomez C, Frontera G. Risk factors for urinary stones in healthy schoolchildren with and without a family hystory of nephrolithiasis. Pedriatr Nephrol. 2013;28:639–45.CrossRef
14.
go back to reference Tiselius HG. Should we modify the principles of risk evaluation and recurrence preventive treatment of patients with calcium oxalate stone disease in view of the etiologic importance of calcium phosphate? Urolithiasis. 2015;43(Suppl 1):47–57.CrossRef Tiselius HG. Should we modify the principles of risk evaluation and recurrence preventive treatment of patients with calcium oxalate stone disease in view of the etiologic importance of calcium phosphate? Urolithiasis. 2015;43(Suppl 1):47–57.CrossRef
15.
go back to reference Forni Ogna V, Ogna A, Vuistiner P, Pruijm M, Ponte B, Ackermann D, et al. New anthropometry-based age- and sex-specific reference values for urinary 24-hour creatinine excretion based on the adult Swiss population. BMC Med. 2015;13:40.CrossRef Forni Ogna V, Ogna A, Vuistiner P, Pruijm M, Ponte B, Ackermann D, et al. New anthropometry-based age- and sex-specific reference values for urinary 24-hour creatinine excretion based on the adult Swiss population. BMC Med. 2015;13:40.CrossRef
16.
go back to reference Remer T, Neubert A, Maser-Gluth C. Anthropometry-based reference values for 24-h urinary creatinine excretion during growth and their use in endocrine and nutritional research. Am J Clin Nutr. 2002;75:561–9.CrossRef Remer T, Neubert A, Maser-Gluth C. Anthropometry-based reference values for 24-h urinary creatinine excretion during growth and their use in endocrine and nutritional research. Am J Clin Nutr. 2002;75:561–9.CrossRef
17.
go back to reference Tiselius HG. Aspects on estimation of the risk of calcium oxalate crystallization in urine. Urol Int. 1991;47:255–9.CrossRef Tiselius HG. Aspects on estimation of the risk of calcium oxalate crystallization in urine. Urol Int. 1991;47:255–9.CrossRef
18.
go back to reference Bek-Jensen H, Tiselius HG. Evaluation of urine composition and calcium salt crystallization properties in standardized volume-adjusted 12-h night urine from normal subjects and calcium oxalate stone formers. Urol Res. 1997;25:365–72.CrossRef Bek-Jensen H, Tiselius HG. Evaluation of urine composition and calcium salt crystallization properties in standardized volume-adjusted 12-h night urine from normal subjects and calcium oxalate stone formers. Urol Res. 1997;25:365–72.CrossRef
19.
go back to reference Skolarikos A, Straub M, Knoll T, Sarica K, Seitz C, Petrik A, et al. Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines. Eur Urol. 2015;67:750–63.CrossRef Skolarikos A, Straub M, Knoll T, Sarica K, Seitz C, Petrik A, et al. Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines. Eur Urol. 2015;67:750–63.CrossRef
20.
go back to reference Pearle MS, Goldfarb DS, Assimos DG, Curhan G, Denu-Ciocca CJ, Matlaga BR, et al. Medical management of kidney stones: AUA guideline. J Urol. 2014;192:316–24.CrossRef Pearle MS, Goldfarb DS, Assimos DG, Curhan G, Denu-Ciocca CJ, Matlaga BR, et al. Medical management of kidney stones: AUA guideline. J Urol. 2014;192:316–24.CrossRef
21.
go back to reference Hsi RS, Sanford T, Goldfarb DS, Stoller ML. The role of the 24-hour urine collection in the prevention of kidney stone recurrence. J Urol. 2017;197:1084–9.CrossRef Hsi RS, Sanford T, Goldfarb DS, Stoller ML. The role of the 24-hour urine collection in the prevention of kidney stone recurrence. J Urol. 2017;197:1084–9.CrossRef
22.
go back to reference Gambaro G, Croppi E, Coe F, Lingeman J, Moe O, Worcester E, et al. Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement. J Nephrol. 2016;29:715–34.CrossRef Gambaro G, Croppi E, Coe F, Lingeman J, Moe O, Worcester E, et al. Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement. J Nephrol. 2016;29:715–34.CrossRef
23.
go back to reference Parks JH, Coward M, Coe FL. Correspondence between stone composition and urine supersaturation in nephrolithiasis. Kidney Int. 1997;51:894–900.CrossRef Parks JH, Coward M, Coe FL. Correspondence between stone composition and urine supersaturation in nephrolithiasis. Kidney Int. 1997;51:894–900.CrossRef
24.
go back to reference Curhan GC, Willett WC, Speizer FE, Stampfer MJ. Twenty-four-hour urine chemistries and the risk of kidney stones among women and men. Kidney Int. 2001;59:2290–8.CrossRef Curhan GC, Willett WC, Speizer FE, Stampfer MJ. Twenty-four-hour urine chemistries and the risk of kidney stones among women and men. Kidney Int. 2001;59:2290–8.CrossRef
25.
go back to reference Coe FL, Worcester EM, Evan AP. Idiopathic hypercalciuria and formation of calcium renal stones. Nat Rev Nephrol. 2016;12:519–33.CrossRef Coe FL, Worcester EM, Evan AP. Idiopathic hypercalciuria and formation of calcium renal stones. Nat Rev Nephrol. 2016;12:519–33.CrossRef
26.
go back to reference Porowski T, Kirejczyk JK, Zoch-Zwierz W, Konstantynowicz J, Korzeniecka-Kozerska A, Motkowski R, et al. Assessment of lithogenic risk in children based on a morning spot urine sample. J Urol. 2010;184:2103–8.CrossRef Porowski T, Kirejczyk JK, Zoch-Zwierz W, Konstantynowicz J, Korzeniecka-Kozerska A, Motkowski R, et al. Assessment of lithogenic risk in children based on a morning spot urine sample. J Urol. 2010;184:2103–8.CrossRef
27.
go back to reference Wagner CA, Mohebbi N. Urinary pH and stone formation. J Nephrol. 2010;23(Suppl 16):S165–9.PubMed Wagner CA, Mohebbi N. Urinary pH and stone formation. J Nephrol. 2010;23(Suppl 16):S165–9.PubMed
28.
go back to reference Grases F, Costa-Bauza A, Gomila I, Ramis M, Garcia-Raja A, Prieto RM. Urinary pH and renal lithiasis. Urol Res. 2012;40:41–6.CrossRef Grases F, Costa-Bauza A, Gomila I, Ramis M, Garcia-Raja A, Prieto RM. Urinary pH and renal lithiasis. Urol Res. 2012;40:41–6.CrossRef
29.
go back to reference Murayama T, Sakai N, Yamada T, Takano T. Role of the diurnal variation of urinary pH and urinary calcium in urolithiasis: a study in outpatients. Int J Urol. 2001;8:525–31.CrossRef Murayama T, Sakai N, Yamada T, Takano T. Role of the diurnal variation of urinary pH and urinary calcium in urolithiasis: a study in outpatients. Int J Urol. 2001;8:525–31.CrossRef
30.
go back to reference Firsov D, Bonny O. Circadian regulation of renal function. Kidney Int. 2010;78:640–5.CrossRef Firsov D, Bonny O. Circadian regulation of renal function. Kidney Int. 2010;78:640–5.CrossRef
Metadata
Title
Effect of sample time on urinary lithogenic risk indexes in healthy and stone-forming adults and children
Authors
Adrian Rodriguez
Concepcion Saez-Torres
Concepcion Mir
Paula Casasayas
Nuria Rodriguez
Dolores Rodrigo
Guiem Frontera
Juan Manuel Buades
Cristina Gomez
Antonia Costa-Bauza
Felix Grases
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Urology / Issue 1/2018
Electronic ISSN: 1471-2490
DOI
https://doi.org/10.1186/s12894-018-0430-8

Other articles of this Issue 1/2018

BMC Urology 1/2018 Go to the issue